🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Published 10/01/2024, 18:06
Updated 10/01/2024, 19:10
© Reuters.  Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
WDFC
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

WD-40 reported quarterly earnings of $1.28 per share which exceeded the analyst consensus estimate of $1.05 per share. The company reported quarterly sales of $140.42 million, clocking in above the Street's estimate of $134.37 million.

WD-40 shares jumped 17.3% to $277.56 on Wednesday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Nauticus Robotics, Inc. (NASDAQ: KITT) climbed 87.8% to $0.5501. Nauticus Robotics secured additional funding and appointed John W. Gibson, Jr as interim CEO.
  • Clearmind Medicine Inc. (NASDAQ: CMND) shares jumped 47.7% to $3.0570. Clearmind Medicine completed a Type A Meeting with the FDA for clinical trial of its proprietary MEAI-based, CMND-100 compound, for the treatment of alcohol use disorder.
  • Sana Biotechnology, Inc. (NASDAQ: SANA) gained 46.8% to $7.57. Sana Biotechnology recently announced FDA clearance of investigational new drug application for SC262.
  • Ucommune International Ltd (NASDAQ: UK) jumped 37.8% to $4.98.
  • Vicarious Surgical Inc. (NASDAQ: RBOT) rose 37% to $0.6851.
  • Nvni Group Limited (NASDAQ: NVNI) climbed 35.2% to $2.6091.
  • EchoStar Corporation (NASDAQ: SATS) gained 31% to $16.50. EchoStar completed merger with DISH Network Corporation.
  • Amarin Corporation plc (NASDAQ: AMRN) climbed 28.8% to $1.25 after the company reported strong preliminary FY23 total revenues.
  • Exicure, Inc. (NASDAQ: XCUR) shares rose 17% to $0.5501. Exicure was granted broad U.S. patent #11866700 for "Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin 17 Mrna (For Inflammation From Cancer, Obesity, Diabetes, Alzheimer's)."
  • NexImmune, Inc. (NASDAQ: NEXI) gained 16.2% to $13.72.
  • Exscientia plc (NASDAQ: EXAI) rose 14% to $7.07. B of A Securities recently downgraded the stock from Buy to Neutral and lowered its price target from $11 to $9.
  • NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) rose 13.6% to $14.00.
  • SMART Global Holdings Inc. (NASDAQ: SGH) gained 13.4% to $20.97 after the companyy posted better-than-expected earnings for its first quarter and announced approval of $75 million share repurchase authorization.
  • Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) jumped 12.4% to $2.7100. Xeris Biopharma entered into an exclusive worldwide license agreement with Amgen for Xeriject formulation of teprotumumab for thyroid eye disease.
  • GoodRx Holdings, Inc. (NASDAQ: GDRX) jumped 11.6% to $6.38. GoodRx sees preliminary FY23 adjusted revenue of $759 million to $761 million.
  • E2open Parent Holdings, Inc. (NYSE: ETWO) surged 11.2% to $4.27 following strong quarterly sales.
  • PriceSmart, Inc. (NASDAQ: PSMT) rose 10% to $80.25 as the company reported better-than-expected earnings for its first quarter on Tuesday.
  • iCoreConnect Inc. (NASDAQ: ICCT) shares rose 9.3% to $1.4203. iCoreConnect announced strategic acquisition of Verifi Dental.
  • AZZ Inc. (NYSE: AZZ) jumped 9.1% to $62.24 following upbeat quarterly results.
  • Intuitive Surgical, Inc. (NASDAQ: ISRG) gained 6.1% to $350.63. Intuitive Surgical said it sees preliminary revenue of $1.93 billion for the fourth quarter, versus market estimates of $1.87 billion.
Losers
  • DocGo Inc. (NASDAQ: DCGO) shares fell 32.9% to $3.2150. Fuzzy Panda Research issued a report and disclosed a short position in the stock.
  • HWH International Inc. (NASDAQ: HWH) shares fell 25.3% to $2.10 after dipping 26% on Tuesday.
  • Aclaris Therapeutics, Inc. (NASDAQ: ACRS) fell 25% to $0.9601 after the company's Phase 2B study of ATI-1777 2% QD was not statistically superior on the primary efficacy endpoint.
  • Presto Automation Inc. (NASDAQ: PRST) fell 19.5% to $0.3127.
  • Roma Green Finance Limited (NASDAQ: ROMA) shares fell 18.8% to $2.3557 after dipping over 27% on Tuesday. Roma Green Finance announced pricing of $12.3 million public offering of 2,449,943 of shares at price of $4.00 per share.
  • Sidus Space, Inc. (NASDAQ: SIDU) fell 16.8% to $14.11. Sidus Space regained compliance with Nasdaq minimum bid requirements.
  • Wearable Devices Ltd. (NASDAQ: WLDS) fell 15.7% to $0.3797.
  • Aehr Test Systems (NASDAQ: AEHR) shares fell 15.1% to $18.97 after the company lowered its full-year revenue guidance.
  • Ainos, Inc. (NASDAQ: AIMD) fell 14.9% to $2.22.
  • GrafTech International Ltd. (NYSE: EAF) fell 14.4% to $1.61.
  • Alaunos Therapeutics, Inc. (NASDAQ: TCRT) declined 12.9% to $0.1335.
  • TG Therapeutics, Inc. (NASDAQ: TGTX) fell 12.4% to $18.38 after the company reported preliminary BRIUMVI US net product sales for Q4 and FY23.
  • Wheels Up Experience Inc. (NYSE: UP) fell 12% to $4.2350.
  • MicroCloud Hologram Inc. (NASDAQ: HOLO) fell 11.9% to $0.2621 after gaining 22% on Tuesday.
  • Veradigm Inc. (NASDAQ: MDRX) fell 11.1% to $9.56. Veradigm said it sees FY23 revenue of $608 million to $622 million.
  • Galera Therapeutics, Inc. (NASDAQ: GRTX) shares fell 9.1% to $0.1919 after jumping 41% on Tuesday.
  • Saratoga Investment Corp. (NYSE: SAR) fell 9.1% to $23.55 following downbeat quarterly earnings.
  • NovoCure Limited (NASDAQ: NVCR) declined 8.8% to $13.43.
  • Sasol Limited (NYSE: SSL) shares fell 6.8% to $9.08.

Now Read This: How To Earn $500 A Month From JPMorgan Stock Ahead Of Q4 Earnings Report

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.